These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1990673

  • 1. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
    Hahn HJ, Kuttler B, Dunger A, Lucke S, Volk HD, Diamantstein T.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
    [No Abstract] [Full Text] [Related]

  • 2. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ, Kuttler B, Lucke S, Dunger A, Besch W, Volk HD, Diamankstein T.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D, Wanka H, Hehmke B, Klöting I, Köhler E, Knospe S, Schmidt S.
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
    Hahn HJ, Kauert C, Dunger A, Kuttler B, Diamantstein T.
    Autoimmunity; 1989 Sep; 5(1-2):139-42. PubMed ID: 2519014
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR, Schmeisser FS, Josephson MA, Sohn DG, Thistlethwaite JR.
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract] [Full Text] [Related]

  • 12. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX, Chowdhury NC, James T, Engelstad K, Hardy MA, Oluwole SF.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S, Mullen Y, Wicker LS, Peterson LB, Nagata M, Tsunoda T, Clare-Salzler M.
    Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
    [No Abstract] [Full Text] [Related]

  • 19. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts.
    Barneo L, Field MJ, Esteban MM.
    Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178
    [No Abstract] [Full Text] [Related]

  • 20. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G, Rossi M, Castagna MT, Radin S, Vecchioni R.
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.